187 related articles for article (PubMed ID: 27395443)
1. Apolipoprotein ɛ4 breaks the association between declarative long-term memory and memory-based orienting of spatial attention in middle-aged individuals.
Salvato G; Patai EZ; McCloud T; Nobre AC
Cortex; 2016 Sep; 82():206-216. PubMed ID: 27395443
[TBL] [Abstract][Full Text] [Related]
2. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study.
Luo X; Qiu T; Xu X; Huang P; Gu Q; Shen Z; Yu X; Jia Y; Guan X; Song R; Zhang M;
J Alzheimers Dis; 2016; 50(4):1137-48. PubMed ID: 26836191
[TBL] [Abstract][Full Text] [Related]
3. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
[TBL] [Abstract][Full Text] [Related]
4. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
[TBL] [Abstract][Full Text] [Related]
5. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
[TBL] [Abstract][Full Text] [Related]
6. Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.
Whitson HE; Potter GG; Feld JA; Plassman BL; Reynolds K; Sloane R; Welsh-Bohmer KA
J Alzheimers Dis; 2018; 64(4):1137-1148. PubMed ID: 30010120
[TBL] [Abstract][Full Text] [Related]
7. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
Oleson S; Murphy C
J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
[TBL] [Abstract][Full Text] [Related]
8. Does possession of apolipoprotein E ɛ4 benefit cognitive function in healthy young adults?
Bunce D; Anstey KJ; Burns R; Christensen H; Easteal S
Neuropsychologia; 2011 Jun; 49(7):1693-7. PubMed ID: 21396385
[TBL] [Abstract][Full Text] [Related]
9. Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-є4.
Olofsson JK; Josefsson M; Ekström I; Wilson D; Nyberg L; Nordin S; Nordin Adolfsson A; Adolfsson R; Nilsson LG; Larsson M
Neuropsychologia; 2016 May; 85():1-9. PubMed ID: 26956928
[TBL] [Abstract][Full Text] [Related]
10. Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.
Du M; Andersen SL; Schupf N; Feitosa MF; Barker MS; Perls TT; Sebastiani P
J Alzheimers Dis; 2021; 79(1):117-125. PubMed ID: 33216038
[TBL] [Abstract][Full Text] [Related]
11. Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein ɛ4 Carriers versus Apolipoprotein ɛ3 Homozygotes.
Sible IJ; Nation DA;
J Alzheimers Dis; 2023; 93(2):533-543. PubMed ID: 37066910
[TBL] [Abstract][Full Text] [Related]
12. Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.
Chen Y; Liu Z; Zhang J; Chen K; Yao L; Li X; Gong G; Wang J; Zhang Z
Hum Brain Mapp; 2017 Jan; 38(1):271-282. PubMed ID: 27593520
[TBL] [Abstract][Full Text] [Related]
13. 25-hydroxyvitamin D, APOE ɛ4 genotype and cognitive function: findings from the 1958 British birth cohort.
Maddock J; Cavadino A; Power C; Hyppönen E
Eur J Clin Nutr; 2015 Apr; 69(4):505-8. PubMed ID: 25293430
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
15. APOE Genotype Differentially Modulates Plasma Lipids in Healthy Older Individuals, with Relevance to Brain Health.
Wong MWK; Braidy N; Crawford J; Pickford R; Song F; Mather KA; Attia J; Brodaty H; Sachdev P; Poljak A
J Alzheimers Dis; 2019; 72(3):703-716. PubMed ID: 31640095
[TBL] [Abstract][Full Text] [Related]
16. Associations of modifiable and non-modifiable risk factors with cognitive functions - a prospective, population-based, 17 years follow-up study of 3,229 individuals.
Glans I; Nägga K; Gustavsson AM; Stomrud E; Nilsson PM; Melander O; Hansson O; Palmqvist S
Alzheimers Res Ther; 2024 Jun; 16(1):135. PubMed ID: 38926747
[TBL] [Abstract][Full Text] [Related]
17. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.
Edlund AK; Chen K; Lee W; Protas H; Su Y; Reiman E; Caselli R; Nielsen HM
J Alzheimers Dis; 2021; 81(1):339-354. PubMed ID: 33814450
[TBL] [Abstract][Full Text] [Related]
18. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele.
Adamson MM; Hutchinson JB; Shelton AL; Wagner AD; Taylor JL
Neuropsychologia; 2011 Jul; 49(9):2448-55. PubMed ID: 21549723
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.
Marchant NL; King SL; Tabet N; Rusted JM
Neuropsychopharmacology; 2010 Apr; 35(5):1090-6. PubMed ID: 20072115
[TBL] [Abstract][Full Text] [Related]
20. Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure.
Bender AR; Raz N
Neuropsychologia; 2012 Apr; 50(5):704-14. PubMed ID: 22245009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
